Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Real-World Cohort Study for the Development and Validation of a Multimodal Artificial Intelligence System to Predict Response to Neoadjuvant Chemo-Immunotherapy in Locally Advanced Gastric Cancer (The PRISM-GC Study)

NCT07401199 is registered in ClinicalTrials.gov with Qun Zhao as lead sponsor.

NCT NCT07401199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07401199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Real-World Cohort Study for the Development and Validation of a Multimodal Artificial Intelligence System to Predict Response to Neoadjuvant Chemo-Immunotherapy in Locally Advanced Gastric Cancer (The PRISM-GC Study)
Lead sponsor
Qun Zhao
Phase
Observational
Overall status
Recruiting
Start date
February 5, 2026
Completion date
December 30, 2027
Enrollment
2,000 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer (gc), locally advanced gastric cancer